Stocks Buzz: Teradata Corporation (TDC), Washington Prime Group Inc. (WPG), Heat Biologics, Inc. (HTBX)

Teradata Corporation (TDC) failed to extend gains with the stock declining -0.31% or $-0.09 to close the day at $29.03 on light trading volume of 1.43M shares, compared to its three month average trading volume of 1.64M. The Dayton Ohio 45342 based company has been outperforming the data storage devices group over the past 52 weeks, with the stock gaining 19.27%, compared to the industry which has advanced 57.92% over the same period. With RSI of 60.4, the stock should still continue to rise and get closer to its one year target estimate of $27.47, making it a hold for now.

Teradata Corporation provides analytic data solutions, marketing and analytic applications, and related services in the United States and internationally. Its analytic data solutions comprise software, hardware, and related business consulting and support services for data warehousing and big data analytics. The company’s products comprise Teradata Database Software that delivers near real-time intelligence; Teradata Workload-Specific Platforms; Teradata Aster Analytics Discovery Platform, which is pre-configured with Teradata Aster Database; Teradata Portfolio for Hadoop; and Teradata QueryGrid that provides access to analytics to various processing engines. It also provides Teradata Integrated Marketing Applications, which help organizations in managing marketing workflows, budget allocation, leads, analytics, and digital assets. In addition, the company provides business consulting services; technology and implementation services; cloud services; and management services for data integration, data warehouse, discovery, Hadoop, and business intelligence environments. Further, it offers customer support services, such as installation, maintenance, monitoring, back-up, and recovery services; training services; and marketing services. The company serves various industries comprising banking/financial services, communications, energy, government, insurance and healthcare, manufacturing, oil and gas, retail, travel and transportation logistics, and utilities. It has strategic partnerships with Accenture, Capgemini, Cognizant Technology Solutions, Deloitte, IBM Global Business Services, and Wipro Limited. Teradata Corporation was founded in 1979 and is headquartered in Dayton, Ohio.

Washington Prime Group Inc. (WPG) retreated with the stock falling -1.48% or $-0.14 to close at $9.31 on light trading volume of 1.43M compared its three months average trading volume of 1.94M. The Columbus Ohio 43215 based company operating under the Property Management industry has been trending up for the last 52 weeks, with the shares price now 12.64% up for the period and down by -10.57% so far this year. With price target of $10.1 and a 38.03% rebound from 52-week low, Washington Prime Group Inc. has plenty of upside potential, making it a hold with a view buy.

Washington Prime Group Inc. (NYSE:WPG.WI) operates independently of Simon Property Group Inc. as of May 28, 2014.

Heat Biologics, Inc. (HTBX) failed to extend gains with the stock declining -7.41% or $-0.08 to close the day at $1 on lower than average trading volume of 1.43M shares, compared to its three month average trading volume of 2.85M. The Durham North Carolina 27713 based company has been outperforming the biotechnology companies by -27.0106% for last three months and its recent losses have trimmed gains to 16.28% YTD, versus the biotechnology industry which is down -6.09% for the same period. The RSI of 39.13 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

 

Stocks Roundup: Simon Property Group, Inc. (SPG), Teradyne, Inc. (TER), Heat Biologics, Inc. (HTBX)

Simon Property Group, Inc. (SPG) retreated with the stock falling -0.93% or $-1.72 to close at $184.19 on active trading volume of 2.67M compared its three months average trading volume of 1.5M. The Indianapolis Indiana 46204 based company operating under the REIT – Retail industry has been trending up for the last 52 weeks, with the shares price now 2.02% up for the period and up by 3.67% so far this year. With price target of $218.65 and a 8.16% rebound from 52-week low, Simon Property Group, Inc. has plenty of upside potential, making it a hold with a view buy.

Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, management, and development of properties. It primarily invests in regional malls, premium outlets, mills, and community/lifestyle centers to create its portfolio. Simon Property Group, Inc. was founded in 1960 and is based in Indianapolis, Indiana, with additional office in New York, New York.

Teradyne, Inc. (TER) had a active trading with around 2.66M shares changing hands compared to its three month average trading volume of 2.05M. The stock traded between $25.68 and $26.35 before closing at the price of $26.31 with 2.29% change on the day. The North Reading Massachusetts 01864 based company is currently trading 53.49% above its 52 week low of $17.34 and -1.05% below its 52 week high of $26.59. Both the RSI indicator and target price of  and $25.11 respectively, lead us to believe that it could rise over the coming weeks.

Teradyne, Inc. designs, develops, manufactures, and sells automatic test equipment worldwide. Its Semiconductor Test segment designs, manufactures, sells, and supports semiconductor test products and services for wafer level and device package testing in automotive, industrial, communications, consumer, computer and electronic game applications, and others. This segment offers FLEX test platform systems; Magnum platform that tests memory devices, such as flash memory and dynamic random access memory; J750 test system to address the highest volume semiconductor devices; and ETS platform for use by semiconductor manufacturers, and assembly and test subcontractors in the low pin count analog/mixed signal discrete markets. It serves integrated device manufacturers (IDMs) that integrate the fabrication of silicon wafers into their business; fabless companies, which outsource the manufacturing of silicon wafers; foundries; and outsourced semiconductor assembly and test providers. The company’s Wireless Test segment designs, develops, and supports wireless test equipment for developing and manufacturing wireless devices, including smart phones, tablets, notebooks, laptops, personal computer peripherals, and other Wi-Fi, Bluetooth, and cellular enabled devices. This segment offers IQxstream solution for testing GSM, EDGE, CDMA2000, TD-SCDMA, WCDMA, HSPA+, LTE-FDD, TD_LTE, and LTE-A technologies for calibration and verification of smartphones, tablets, small cell wireless gateways, and embedded cellular modules; test equipment for connectivity testing; IQfact chipset software; and modular wireless test instruments. The company’s System Test segment offers defense/aerospace test instrumentation and systems; storage test systems; and circuit-board test and inspection systems. Its Industrial Automation segment provides collaborative robots for manufacturing and light industrial customers. The company was founded in 1960 and is headquartered in North Reading, Massachusetts.

Heat Biologics, Inc. (HTBX) saw its value increase by 8.1% as the stock gained $0.08 to finish the day at a closing price of $1.06. The stock was lighter in trading and has fluctuated between $0.401-$3.61 per share for the past year. The shares are down by -10.22% in the past three months and up by 51.34% over the past six months. It is currently trading 22.19% above its 20 day moving average and -17.26% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $4 a share over the next twelve months. The current relative strength index (RSI) reading is 52.67.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

 

Stocks on the Move: InvenSense, Inc. (INVN), Union Pacific Corporation (UNP), Heat Biologics, Inc. (HTBX)

InvenSense, Inc. (INVN) managed to rebound with the stock climbing 0.31% or $0.04 to close the day at $12.8 on active trading volume of 3.87M shares, compared to its three month average trading volume of 2.79M. The San Jose California 95110 based company has been outperforming the semiconductor – integrated circuits group over the past 52 weeks, with the stock gaining 38.83%, compared to the industry which has advanced 45.11% over the same period. With RSI of 83.29, the stock should still continue to rise and get closer to its one year target estimate of $11.64, making it a hold for now.

InvenSense, Inc. designs, develops, manufactures, markets, and sells sensor systems on a chip in the United States, China, Taiwan, South Korea, Japan, France, Canada, Slovakia, and Italy. It offers accelerometers, gyroscopes, and microphones for the mobile, wearable, smart home, gaming, industrial, and automotive market segments. The company delivers solutions based on motion and sound technology to smartphones, tablets, wearables, console and portable video gaming devices, digital television and set-top box remote controls, fitness accessories, sports equipment, digital still cameras, automobiles, ultra-books, laptops, hearing aids, stabilization systems, tools, navigation devices, remote controlled toys, and other household consumer and industrial devices. It also provides sensor data analytics platforms and services. The company sells its products to consumer electronics device manufacturers, original design manufacturers, and contract manufacturers directly, as well as through distributors. InvenSense, Inc. has a collaboration with Panasonic Corporation for the development of sensor technology solutions and automotive safety micro electrical mechanical systems based inertial sensors. The company was founded in 2003 and is headquartered in San Jose, California.

Union Pacific Corporation (UNP) climbed 1.04% during last trading as the stock added $1.06 to finish the day at $103.19 with about 3.86M shares changing hands, compared to its three month average trading volume of 4.28M. The $85.65B market cap company, which fluctuated between $101.2 and $103.77 during the day, currently situated 57.82% above its 52 week low of $67.06 and -3.22% away from its one year high of $106.62. The RSI of 54.98 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers freight transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal and petroleum coke; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export containers and trailers. Union Pacific Corporation’s rail network includes 32,084 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and eastern United States gateways. The company was founded in 1862 and is headquartered in Omaha, Nebraska.

Heat Biologics, Inc. (HTBX) saw its value increase by 8.07% as the stock gained $0.07 to finish the day at a closing price of $0.95. The stock was higher in trading and has fluctuated between $0.4-$3.35 per share for the past year. The shares, which traded within a range of $0.869 to $1.06 during the day, are down by -28.5% in the past three months and up by 44.09% over the past six months. It is currently trading 8.01% above its 20 day moving average and -26.73% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $4 a share over the next twelve months. The current relative strength index (RSI) reading is 47. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

 

Stocks in Focus: Fred’s, Inc. (FRED), KeyCorp (KEY), Heat Biologics, Inc. (HTBX)

Fred’s, Inc. (FRED) had a light trading with around 6.96M shares changing hands compared to its three month average trading volume of 770.93K. The stock traded between $19.57 and $20.54 before closing at the price of $20.35 with 0.79% change on the day. The Memphis Tennessee 38118 based company is currently trading 159.55% above its 52 week low of $7.89 and -6.52% below its 52 week high of $21.77. Both the RSI indicator and target price of 90.79 and $9.6 respectively, lead us to believe that it could drop over the coming weeks.

Fred’s, Inc., together with its subsidiaries, sells general merchandise through its retail discount stores and full service pharmacies. The company, through its stores, offers household cleaning supplies, health and beauty aids, disposable diapers, pet foods, paper products, various food and beverage products, and pharmaceuticals to low, middle, and fixed income families in small- to medium- sized towns. It also sells general merchandise to franchised Fred’s stores. As of January 30, 2016, the company operated 641 company-owned stores, which included 60 express stores in 15 states and 18 franchised stores under the Fred’s name, as well as 372 pharmacies and 3 specialty pharmacy facilities primarily in the southeastern United States. It also operates 18 franchised stores under the Fred’s name. Fred’s, Inc. was founded in 1947 and is headquartered in Memphis, Tennessee.

KeyCorp (KEY) failed to extend gains with the stock declining -0.76% or $-0.14 to close the day at $18.32 on active trading volume of 6.92M shares, compared to its three month average trading volume of 16.7M. The Cleveland Ohio 44114 based company has been outperforming the regional – midwest banks group over the past 52 weeks, with the stock gaining 44.61%, compared to the industry which has advanced 32.38% over the same period. With RSI of 69.11, the stock should still continue to rise and get closer to its one year target estimate of $18.06, making it a hold for now.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States. The company’s Key Community Bank segment offers deposit and investment products; personal finance services and loans, including residential mortgages, home equity, credit cards, and various installment loans for individuals; deposits, investment and credit products, and business advisory services to small businesses; and financial, estate and retirement planning, and asset management services to high-net-worth clients. This segment also provides commercial lending, cash management, equipment leasing, investment and employee benefit programs, succession planning, access to capital markets, derivatives, and foreign exchange services to mid-sized businesses. Its Key Corporate Bank segment offers a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans for middle market clients comprising consumer, energy, healthcare, industrial, public, real estate, and technology sectors. In addition, KeyCorp provides personal, securities lending, and custody services; access to mutual funds; treasury, investment banking, international banking, and investment management services; public retirement plans, and foundations and endowments plans; and financial services consisting of community development financing, securities underwriting, and brokerage, as well as merchant services. As of December 31, 2015, the company operated 966 retail banking branches and 1,257 automated teller machines in 12 states, as well as a telephone banking call center. KeyCorp was founded in 1849 and is headquartered in Cleveland, Ohio.

Heat Biologics, Inc. (HTBX) shares were up in last trading by 31.85% to $1.01. It experienced higher than average volume on day. The stock increased in value by almost 27.85% over the past week and fell -30.34% in the past month. It is currently trading -25.83% below its 50 day moving average and -2.31% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -78.56% decrease in value from its one year high of $4.71. The RSI indicator value of 45.46, lead us to believe that it is a hold for now.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

 

Equities Trend Analysis: Costco Wholesale Corporation (COST), Heat Biologics, Inc. (HTBX), RSP Permian, Inc. (RSPP)

Costco Wholesale Corporation (COST) grew with the stock adding 0.24% or $0.4 to close at $163.86 on light trading volume of 2.2M compared its three months average trading volume of 2.51M. The Issaquah Washington 98027 based company operating under the Discount, Variety Stores industry has been trending up for the last 52 weeks, with the shares price now 3.98% up for the period and up by 2.63% so far this year. With price target of $170.5 and a 18.93% rebound from 52-week low, Costco Wholesale Corporation has plenty of upside potential, making it a hold with a view buy.

Costco Wholesale Corporation, together with its subsidiaries, operates membership warehouses. It offers branded and private-label products in a range of merchandise categories. The company provides dry and packaged foods, and groceries; snack foods, candies, alcoholic and nonalcoholic beverages, and cleaning supplies; appliances, electronics, health and beauty aids, hardware, and garden and patio; meat, bakery, deli, and produces; and apparel and small appliances. It also operates gas stations, pharmacies, optical dispensing centers, food courts, and hearing-aid centers; and engages in the travel businesses. In addition, the company provides gold star individual and business membership services. As of August 28, 2016, it operated 715 warehouses, including 501 warehouses in the United States, Washington, District of Columbia, and Puerto Rico; 91 in Canada; 36 in Mexico; 28 in the United Kingdom; 25 in Japan; 12 in Korea; 12 in Taiwan; 8 in Australia; and 2 in Spain. Further, the company sells its products through online. The company was formerly known as Costco Companies, Inc. Costco Wholesale Corporation was founded in 1976 and is based in Issaquah, Washington.

Heat Biologics, Inc. (HTBX) had a light trading with around 2.2M shares changing hands compared to its three month average trading volume of 2.36M. The stock traded at the price of $0.77 with 10.01% change on the day. The Durham North Carolina 27713 based company is currently trading 91.5% above its 52 week low of $0.401 and -83.74% below its 52 week high of $4.71. Both the RSI indicator and target price of  and $3 respectively, lead us to believe that it could rise over the coming weeks.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

RSP Permian, Inc. (RSPP) saw its value increase by 0.71% as the stock gained $0.32 to finish the day at a closing price of $45.2. The stock was lighter in trading and has fluctuated between $16.74-$46.44 per share for the past year. The shares, which traded within a range of $44.74 to $46.12 during the day, are up by 17.95% in the past three months and up by 27.18% over the past six months. It is currently trading 4.94% above its 20 day moving average and 10.26% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $51.5 a share over the next twelve months. The current relative strength index (RSI) reading is 61.91.The technical indicator lead us to believe there will be no major movement any time soon, hold.

RSP Permian, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin of West Texas. It owns interest in contiguous acreage blocks in the core of the Midland Basin, a sub-basin of the Permian Basin, primarily in the adjacent counties of Midland, Martin, Andrews, Dawson, Ector, and Glasscock. RSP Permian, Inc. was founded in 2010 and is headquartered in Dallas, Texas.

 

Trader Alert: Kohl’s Corporation (KSS), Avon Products, Inc. (AVP), Heat Biologics, Inc. (HTBX)

Kohl’s Corporation (KSS) grew with the stock adding 2.78% or $1.61 to close at $59.43 on active trading volume of 5.31M compared its three months average trading volume of 3.78M. The Menomonee Falls Wisconsin 53051 based company operating under the Department Stores industry has been trending up for the last 52 weeks, with the shares price now 31.82% up for the period and up by 30.43% so far this year. With price target of $52.68 and a 81.49% rebound from 52-week low, Kohl’s Corporation has plenty of upside potential, making it a hold with a view buy.

Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers. The company also sells its products online through Website Kohls.com. As of January 30, 2016, it operated 1,164 department stores in 49 states. Kohl’s Corporation was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.

Avon Products, Inc. (AVP) gained $0.14 to close the day at a new closing price of $5.53, a 2.6% increase in value from its previous closing price that moved the stock 150.23% above its 52 week low of $2.21. A total of 5.3M shares exchanged hands during the day compared with its three month average trading volume of 5.45M. The stock, which fluctuated between $5.33 and $5.57 during the day, currently situated -20.55% below its 52 week high. The stock is down by -9.34% in the past one month and up by 1.65% over the past three months. With a one year target estimate of $6.41 and RSI of 48.16, the stock still has upside potential, making it a hold for now.

Avon Products, Inc. manufactures and markets beauty and related products worldwide. It offers beauty products, which consists of skincare products, including personal care products, as well as fragrances and color cosmetics; and fashion and home products consisting of jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products, and nutritional products. The company markets its products through direct selling by representatives. Avon Products, Inc. was founded in 1886 and is headquartered in New York, New York.

Heat Biologics, Inc. (HTBX) shares were down in last trading by -11.97% to $1.03. It experienced higher than average volume on day. The stock decreased in value by almost 0% over the past week and fell -27.46% in the past month. It is currently trading -29.01% below its 50 day moving average and -1.09% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -78.13% decrease in value from its one year high of $4.71. The RSI indicator value of 41.34, lead us to believe that it is a hold for now.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

Trader’s Round Up: The Walt Disney Company (DIS), Genworth Financial, Inc. (GNW), Heat Biologics, Inc. (HTBX)

The Walt Disney Company (DIS) grew with the stock adding 0.7% or $0.7 to close at $100.66 on active trading volume of 8.4M compared its three months average trading volume of 7.94M. The Burbank California 91521 based company operating under the Entertainment – Diversified industry has been trending down for the last 52 weeks, with the shares price now -10.36% down for the period and down by -3.51% so far this year. With price target of $106.75 and a 17.56% rebound from 52-week low, The Walt Disney Company has plenty of upside potential, making it a hold with a view buy.

The Walt Disney Company, together with its subsidiaries, operates as an entertainment company worldwide. The company’s Media Networks segment operates cable programming services, including the ESPN, Disney channels, and Freeform networks; broadcast businesses, which include the ABC TV Network and eight owned television stations; radio businesses consisting of the ESPN Radio Network; and the Radio Disney network. It also produces and sells original live-action and animated television programming to first-run syndication and other television markets, as well as subscription video on demand services and in home entertainment formats, such as DVD, Blu-Ray, and iTunes. Its Parks and Resorts segment owns and operates the Walt Disney World Resort in Florida and the Disneyland Resort in California. This segment also operates Disney Resort & Spa in Hawaii, Disney Vacation Club, Disney Cruise Line, and Adventures by Disney; and manages Disneyland Paris, Hong Kong Disneyland Resort, and Shanghai Disney Resort, as well as licenses its intellectual property to a third party for the operations of the Tokyo Disney Resort in Japan. The company’s Studio Entertainment segment produces and acquires live-action and animated motion pictures for distribution in the theatrical, home entertainment, and television markets primarily under the Walt Disney Pictures, Pixar, Marvel, Lucasfilm, and Touchstone banners. This segment also produces stage plays and musical recordings; licenses and produces live entertainment events; and provides visual and audio effects, and other post-production services. Its Consumer Products & Interactive Media segment licenses its trade names, characters, and visual and literary properties; develops and publishes games for mobile platforms; and sells its products through The Disney Store, DisneyStore.com, and MarvelStore.com, as well as directly to retailers. The company was founded in 1923 and is based in Burbank, California.

Genworth Financial, Inc. (GNW) gained $0.11 to close the day at a new closing price of $4.33, a 2.61% increase in value from its previous closing price that moved the stock 175.8% above its 52 week low of $1.57. A total of 8.36M shares exchanged hands during the day compared with its three month average trading volume of 10.1M. The stock, which fluctuated between $4.23 and $4.34 during the day, currently situated -17.84% below its 52 week high. The stock is up by 7.71% in the past one month and down by -9.03% over the past three months. With a one year target estimate of $4.81 and RSI of 48.84, the stock still has upside potential, making it a hold for now.

Genworth Financial, Inc. provides insurance and homeownership solutions in the United States and internationally. It operates through five segments: U.S. Mortgage Insurance, Canada Mortgage Insurance, Australia Mortgage Insurance, U.S. Life Insurance, and Runoff. The U.S. Mortgage Insurance segment offers mortgage insurance products primarily insure prime-based and individually underwritten residential mortgage loans. The Canada Mortgage Insurance segment provides flow mortgage insurance; and bulk mortgage insurance products and services that aid in the sale of mortgages to the capital markets, as well as helps lenders manage capital and risk in Canada. The Australia Mortgage Insurance segment offers flow mortgage insurance, as well as bulk mortgage insurance that aids in the sale of mortgages to the capital markets in Australia. The U.S. Life Insurance segment offers long-term care insurance products, as well as service traditional life insurance and fixed annuity products in the United States. The Runoff segment covers non-strategic products, which primarily include variable annuity, variable life insurance, institutional, corporate-owned life insurance, and accident and health insurance products. This segment’s institutional products include funding agreements, funding agreements backing notes, and guaranteed investment contracts. It distributes its products and services primarily through appointed independent producers, financial intermediaries, employer groups, and sales specialists. Genworth Financial, Inc. was founded in 2003 and is headquartered in Richmond, Virginia.

Heat Biologics, Inc. (HTBX) shares were up in last trading by 8.11% to $1.2. It experienced higher than average volume on day. The stock decreased in value by almost -59.73% over the past week and fell -7.69% in the past month. It is currently trading -17.82% below its 50 day moving average and 15.03% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -74.52% decrease in value from its one year high of $4.71. The RSI indicator value of 43.44, lead us to believe that it is a hold for now.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

 

Equities Trend Analysis: Lowe’s Companies, Inc. (LOW), Mondelez International, Inc. (MDLZ), Heat Biologics, Inc. (HTBX)

Lowe’s Companies, Inc. (LOW) grew with the stock adding 0.48% or $0.35 to close at $72.66 on active trading volume of 7.49M compared its three months average trading volume of 6.45M. The Mooresville North Carolina 28117 based company operating under the Home Improvement Stores industry has been trending down for the last 52 weeks, with the shares price now -3.73% down for the period and down by -2.82% so far this year. With price target of $78.21 and a 17.53% rebound from 52-week low, Lowe’s Companies, Inc. has plenty of upside potential, making it a hold with a view buy.

Lowe’s Companies, Inc. operates as a home improvement retailer. It offers products for home maintenance, repair, remodeling, and decorating. The company provides home improvement products in various categories, such as lumber and building materials, tools and hardware, appliances, fashion fixtures, rough plumbing and electrical, lawn and garden, seasonal living, paint, flooring, millwork, kitchens, outdoor power equipment, and home fashions. It also offers installation services through independent contractors in various product categories; extended protection plans; and in-warranty and out-of-warranty repair services. The company sells its national brand-name merchandise and private branded products to homeowners, renters, and professional customers; and retail customers comprising individual homeowners and renters. As of January 29, 2016, it operated 1,857 home improvement and hardware stores in the United States, Canada, and Mexico. The company also sells its products through online sites comprising Lowes.com, Lowes.ca, and ATGstores.com, as well as through mobile applications. Lowe’s Companies, Inc. was founded in 1946 and is based in Mooresville, North Carolina.

Mondelez International, Inc. (MDLZ) had a light trading with around 7.46M shares changing hands compared to its three month average trading volume of 8.58M. The stock traded at the price of $41.03 with -0.34% change on the day. The Deerfield Illinois 60015 based company is currently trading 15.83% above its 52 week low of $35.88 and -11.57% below its 52 week high of $46.4. Both the RSI indicator and target price of  and $49.53 respectively, lead us to believe that it could rise over the coming weeks.

Mondelez International, Inc., through its subsidiaries, manufactures and markets snack food and beverage products worldwide. The company offers biscuits, including cookies, crackers, and salted snacks; chocolates, and gums and candies; powdered beverages and coffee; and cheese and grocery products. Its primary brand portfolio includes LU, Nabisco and Oreo biscuits; Cadbury, Cadbury Dairy Milk, and Milka chocolates; Trident gum; Jacobs Kaffee; and Tang powdered beverages. Mondelez International, Inc. sells its products to supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, distributors, convenience stores, gasoline stations, drug stores, value stores, and other retail food outlets through direct store delivery, company owned and satellite warehouses, distribution centers, and other facilities, as well as through independent sales offices and agents. The company was formerly known as Kraft Foods Inc. and changed its name to Mondelez International, Inc. in October 2012. Mondelez International, Inc. was founded in 2000 and is based in Deerfield, Illinois.

Heat Biologics, Inc. (HTBX) saw its value decrease by -10.48% as the stock dropped $-0.13 to finish the day at a closing price of $1.11. The stock was higher in trading and has fluctuated between $0.4-$4.71 per share for the past year. The shares are down by -14.62% in the past three months and up by 91.38% over the past six months. It is currently trading -35.03% below its 20 day moving average and -24.33% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $4.5 a share over the next twelve months. The current relative strength index (RSI) reading is 41.76.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

 

Investor’s Alert: Frontier Communications Corporation (FTR), Heat Biologics, Inc. (HTBX), Rite Aid Corporation (RAD)

Frontier Communications Corporation (FTR) continued its downward trend with the stock declining -0.85% or $-0.03 to close the day at $3.48 on lower than average trading volume of 14.27M shares, compared to its three month average trading volume of 22.46M. The Norwalk Connecticut 06851 based company has been underperforming the telecom services – domestic companies by -21.8664% for last three months and its recent losses have pulled the stock down -20.68% YTD, versus the telecom services – domestic industry which is up 14.38% for the same period. The RSI of 44.46 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Frontier Communications Corporation provides regulated and unregulated voice, data, and video services to residential, business, and wholesale customers in the United States. The company offers residential services, such as fiber-to-the-home and fiber-to-the-node broadband, as well as traditional copper-based broadband products; and commercial services, including Ethernet, dedicated Internet, multiprotocol label switching, time division multiplexing, data transport services, and optical transport services. It also provides Frontier Secure suite of products for computer security, cloud backup and sharing, identity protection, equipment insurance, and technical support; unified messaging services comprising call forwarding, conference calling, caller identification, voicemail, and call waiting services; long distance network services; and packages of communications services. In addition, the company offers switched access services that facilitate other carriers to use the company’s facilities to originate and terminate their local and long distance voice traffic; satellite TV video services; and a range of third-party communications equipment to small, medium, and enterprise business customers. As of December 31, 2015, it had approximately 3,124,200 residential customers; approximately 289,200 business customers; and 2,462,100 broadband subscribers. The company also operates a retail store in Southern California. The company was formerly known as Citizens Communications Company and changed its name to Frontier Communications Corporation in July 2008. Frontier Communications Corporation was founded in 1927 and is based in Norwalk, Connecticut.

Heat Biologics, Inc. (HTBX) had a active trading with around 13.81M shares changing hands compared to its three month average trading volume of 1.73M. The stock traded at the price of $1.24 with 20.39% change on the day. The Durham North Carolina 27713 based company is currently trading 210% above its 52 week low of $0.4 and -73.67% below its 52 week high of $4.71. Both the RSI indicator and target price of 43.25 and $4.5 respectively, lead us to believe that it should be put on hold over the coming weeks.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

Rite Aid Corporation (RAD) traded within a range of $8.01 to $8.15 after opening the day at $8.07. The company has seen its stock increase in value by 2.17% so far this year. The stock was up close to 0.38% on light volume in last trading session and closed at $8.01 per share. After the recent gain, the stock is currently holding -3.49% below its 52 week high of $8.3 and 26.54% above its 12-month low of $6.33. The shares are up by over 5.53% in the last three months, and the RSI indicator value of 64.34 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy Segment sells prescription drugs; and a range of other merchandises, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides health coaching, shared decision making tools, and health care analytics, including health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. The Pharmacy Services Segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. It also offers integrated mail-order and specialty pharmacy services; and performs prescription adjudication services for other PBMs. Rite Aid Corporation has a strategic alliance with GNC. As of February 27, 2016, the company operated approximately 4,561 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

 

Stocks Intraday Alert: Activision Blizzard, Inc. (ATVI), Starbucks Corporation (SBUX), Heat Biologics, Inc. (HTBX)

Activision Blizzard, Inc. (ATVI) continued its downward trend with the stock declining -2.81% or $-1.03 to close the day at $35.58 on lower than average trading volume of 12.37M shares, compared to its three month average trading volume of 9.43M. The Santa Monica California 90405 based company has been underperforming the multimedia & graphics software companies by -15.4882% for last three months and its recent losses have pulled the stock down -7.34% YTD, versus the multimedia & graphics software industry which is up 1.69% for the same period. The RSI of 28.2 indicates the stock is oversold at the current levels, buy for now.

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games. The company operates through two segments, Activision Publishing, Inc. and Blizzard Entertainment, Inc. The company develops, publishes, and sells interactive software products and content through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes subscription-based massively multiplayer online role-playing games; and strategy and role-playing games. In addition, the company maintains a proprietary online gaming service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it engages in creating original film and television content; and provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases in the United States, Canada, Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, the Netherlands, Australia, South Korea, China, and internationally. Activision Blizzard, Inc. is headquartered in Santa Monica, California.

Starbucks Corporation (SBUX) had a light trading with around 12.19M shares changing hands compared to its three month average trading volume of 9.14M. The stock traded at the price of $58.51 with 0.93% change on the day. The Seattle Washington 98134 based company is currently trading 15.62% above its 52 week low of $50.84 and -5.04% below its 52 week high of $62.54. Both the RSI indicator and target price of 75.32 and $64.33 respectively, lead us to believe that it could drop over the coming weeks.

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; China/Asia Pacific; Europe, Middle East, and Africa; and Channel Development. Its stores offer coffee and tea beverages, packaged roasted whole bean and ground coffees, single-serve and ready-to-drink coffee and tea products, juices, and bottled water; an assortment of fresh food and snack offerings; and various food products, such as pastries, breakfast sandwiches, and lunch items, as well as beverage-making equipment and accessories. The company also licenses its trademarks through licensed stores, and grocery and national foodservice accounts. It offers its products under the Starbucks, Teavana, Tazo, Seattle’s Best Coffee, Evolution Fresh, La Boulange, Ethos, Frappuccino, Starbucks Doubleshot, Starbucks Refreshers, and Starbucks VIA brand names. As of November 3, 2016, the company operated 25,085 stores. Starbucks Corporation was founded in 1985 and is based in Seattle, Washington.

Heat Biologics, Inc. (HTBX) opening the day at $1.16. The company has seen its stock decrease in value by -57.79% so far this year. The stock was down close to -64.11% on active volume in last trading session and closed at $1.03 per share. After the recent fall, the stock is currently holding -78.13% below its 52 week high of $4.71 and 157.5% above its 12-month low of $0.4. The shares are down by over -24.26% in the last three months, and the RSI indicator value of 39.97 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.